Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial

Safety and immunogenicity of two formulations of a live-attenuated tetravalent dengue virus (TDEN) vaccine produced using rederived master seeds from a precursor vaccine were tested against a placebo control in a phase II, randomized, double blind trial (NCT00370682). Two doses were administered 6 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanaveeradej, Veerachai, Gibbons, Robert V., Simasathien, Sriluck, Nisalak, Ananda, Jarman, Richard G., Kerdpanich, Angkool, Tournay, Elodie, De La Barrerra, Rafael, Dessy, Francis, Toussaint, Jean-François, Eckels, Kenneth H., Thomas, Stephen J., Innis, Bruce L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080550/
https://www.ncbi.nlm.nih.gov/pubmed/24865677
http://dx.doi.org/10.4269/ajtmh.13-0452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080550/
https://www.ncbi.nlm.nih.gov/pubmed/24865677
http://dx.doi.org/10.4269/ajtmh.13-0452

Ejemplares similares